Tianjin Conjustar Biotechnology Co., Ltd.
PrivateLast Round
Early Funding
Mar 25, 2025
Total Funding Raised
$41.55M
Company Overview
Tianjin Conjustar Biotechnology Co., Ltd. is a biotechnology company that researches and develops peptide-drug conjugates and nanobody-drug conjugates for oncology treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tianjin Conjustar Biotechnology Co., Ltd. Comparables
Compare Tianjin Conjustar Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MultiValent Biotherapies | 83% | |
| AnexAPep Inc. | 83% | |
| Cybrexa Therapeutics | 82% | |
Tianjin Conjustar Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 25, 2025 | ||||
| Angel | Feb 1, 2023 | ||||
| Seed | Mar 1, 2022 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2023
Raised $8.05M in an angel funding round.
- Mar 1, 2022
$7.17M round with Fosun Health Capital and WuXi AppTec
Tianjin Conjustar Biotechnology Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tianjin Conjustar Biotechnology Co., Ltd.'s valuation, stock price, and market status.